Catalyst Pharmaceutical CPRX Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $755.86M+6.6% | $709.17M+2.8% | $689.89M+5.7% | $652.8M+12.4% | $580.66M+12.2% | ||
| $130.83M+3.4% | $126.48M+18.9% | $106.41M+61.6% | $65.86M-7.6% | $71.27M+8.8% | ||
| $34.93M-6.0% | $37.17M+32.6% | $28.03M+50.3% | $18.65M-5.7% | $19.78M+1.2% | ||
| $940.39M+5.2% | $894.03M+4.9% | $852.45M+12.4% | $758.74M+10.6% | $685.72M+10.0% | ||
| $994K-4.1% | $1.04M-3.7% | $1.08M-6.3% | $1.15M-7.3% | $1.24M-8.5% | ||
| $121.97M-7.4% | $131.67M+2.4% | $128.64M-6.8% | $137.98M-6.3% | $147.33M-6.0% | ||
| $27.29M+21.1% | $22.54M+17.6% | $19.17M-9.8% | $21.26M-12.2% | $24.21M+12.3% | ||
| $1.15B+4.0% | $1.1B+5.0% | $1.05B+8.2% | $971.92M+6.9% | $908.87M+6.7% | ||
| $7.15M-36.2% | $11.2M+23.2% | $9.1M+64.5% | $5.53M-50.6% | $11.2M-32.5% | ||
| $132.4M-10.0% | $147.15M+14.3% | $128.74M+13.9% | $113.01M+1.2% | $111.65M-7.5% | ||
| $134.91M-9.9% | $149.71M+14.0% | $131.36M+13.3% | $115.89M+1.1% | $114.59M-7.4% | ||
| $122K-0.8% | $123K0.0% | $123K+0.8% | $122K0.0% | $122K+0.8% | ||
| $523.35M+10.4% | $474.19M+6.1% | $446.79M+13.4% | $394.01M+15.2% | $341.9M+19.9% | ||
| $1.01B+6.1% | $954.27M+3.7% | $920.25M+7.5% | $856.03M+7.8% | $794.28M+9.2% | ||
| $1.15B+4.0% | $1.1B+5.0% | $1.05B+8.2% | $971.92M+6.9% | $908.87M+6.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Catalyst Pharmaceutical's total assets?
- Catalyst Pharmaceutical (CPRX) holds $1.1B in total assets, up 26.3% year over year.
- How much debt does Catalyst Pharmaceutical have?
- Catalyst Pharmaceutical carries $2.7M in total debt against $1.0B of shareholders' equity, a debt-to-equity ratio of 0.00.
- How much cash does Catalyst Pharmaceutical have?
- Catalyst Pharmaceutical holds $755.9M in cash and equivalents.
- Can Catalyst Pharmaceutical cover its short-term obligations?
- Its current ratio is 7.10 — current assets exceed current liabilities.
- Where does Catalyst Pharmaceutical's balance sheet data come from?
- Every line is extracted from Catalyst Pharmaceutical's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
